EU ingredient rules · 1 min read

Hydroxyapatite in cosmetics: EU rules

Quick answer: Hydroxyapatite is a restricted cosmetic ingredient in the EU: Annex III (entry 372) allows it only within set limits. CosIng lists its functions as abrasive, bulking, oral care and skin conditioning.

Key facts

Hydroxyapatite at a glance
INCI nameHYDROXYAPATITE
CAS number1306-06-5
EC number215-145-7
EU statusRestricted (Annex III, entry 372)
Functions (CosIng)Abrasive, Bulking, Oral care, Skin conditioning

CosIng description: Hydroxyapatite is a mineral obtained from pearl oyster shells, salmon bones, phosphate rock, or derived synthetically. It conforms generally to the formula

What it does in a product

  • Abrasive: Scrubs or polishes the surface it is applied to, as in face scrubs and toothpaste.
  • Bulking: Adds volume to a product, often to dilute other solids.
  • Oral care: Used in products for the teeth and mouth.
  • Skin conditioning: Keeps skin in good condition.

Annex III: restricted substances, entry 372

Annex III lists substances that cosmetics may contain only within the limits set there, such as a maximum concentration, the product types they may be used in, and warnings that must appear on the label.

Maximum concentration in the ready-to-use product
Product typeMaximum
Toothpaste10%
Mouthwash0.465%

Other conditions:

Most recent legal act listed by CosIng for this entry: Regulation (EU) 2024/858.

Scientific Committee on Consumer Safety (SCCS) opinions:

Why it matters for shelf life

The EU rules above cover what may go into a product, not how long it lasts. For that, follow the period after opening (the open-jar symbol) or the date printed on the pack, and stop using anything that has changed in smell, color or texture.

Not sure how to read a label? What an INCI name is · How ingredient lists work

Source

European Commission, CosIng (Cosmetic Ingredients database), entries for HYDROXYAPATITE and Annex III/372, retrieved 2026-10-11. CosIng is provided for information only and has no legal value; the legally binding text is Regulation (EC) No 1223/2009 and its amendments as published in the Official Journal of the European Union. Rules outside the EU, for example in the US, can differ. This page is not legal or medical advice.